Trial NCT02992132

View at ClinicalTrials.gov 
Org. Study IDs: ACP-103-032
Secondary IDs: 2016-001127-32

Last trial update was posted on 2019-03-28

MeSH Interventions

Pimavanserin

MeSH Conditions

Aggression Alzheimer Disease Psychomotor Agitation

Other Conditions

Agitation and Aggression in Alzheimer's Disease

Stopping Reasons

N/A

Limitations And Caveats

The original study (n=432) was powered to detect a treatment effect on CMAI, however recruitment was discontinued early for business reasons and amended accordingly The final study (n=111) was no longer adequately powered to detect a treatment effect

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID